scholarly journals Effect of Evening Primrose Oil on Korean Patients With Mild Atopic Dermatitis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Study

2018 ◽  
Vol 30 (4) ◽  
pp. 409 ◽  
Author(s):  
Bo Young Chung ◽  
Sook Young Park ◽  
Min Je Jung ◽  
Hye One Kim ◽  
Chun Wook Park
Keyword(s):  
Atopic Dermatitis ◽  
Clinical Study ◽  
Evening Primrose Oil ◽  
Evening Primrose ◽  
Korean Patients ◽  
Double Blinded ◽  
Controlled Clinical Study

scholarly journals Synergistic Effects of Korean Red Ginseng Extract and the Conventional Systemic Therapeutics of Atopic Dermatitis in a Murine Model

Nutrients ◽  
2021 ◽  
Vol 14 (1) ◽  
pp. 133
Author(s):  
Yu Ri Woo ◽  
Seok Hoon Moon ◽  
Jeesuk Yu ◽  
Sang Hyun Cho
Keyword(s):  
Atopic Dermatitis ◽  
Synergistic Effects ◽  
Transepidermal Water Loss ◽  
Evening Primrose Oil ◽  
Red Ginseng ◽  
Korean Red Ginseng ◽  
Ginseng Extract ◽  
Evening Primrose ◽  
Group A ◽  
Ad Mouse Model

The synergistic effects of Korean Red ginseng (KRG, Panax ginseng C.A. Mey.) on conventional systemic therapeutics of atopic dermatitis (AD) have not been studied yet. To analyze the synergistic effects of KRG extract and the conventional systemic therapeutics of AD in TNCB-induced AD mouse model, we determined the change in modified scoring of index, the transepidermal water loss, the skin pathology, serum IgE, and the expression of various cytokines after combination treatment to the five-week-old NC/Nga female mice. The severity of AD was significantly decreased in the KRG + hydroxyzine (AH) group than AH group, and in the KRG + evening primrose oil (EPO) group than EPO group. A significant decrease in dermal inflammation was observed in the KRG + AH group than that in the AH group, and in the KRG + EPO group than that in the EPO group (p = 0.008), respectively. A decrease in CD1a expression was observed in the KRG + AH group when compared to the AH group (p = 0.008), and KRG + EPO group when compared to the EPO group. Compared to the CS group, the KRG + CS group showed a significant decrease in IL-17 expression. A combination of KRG and conventional systemic therapeutics can safely and effectively manage the AD.

Sign in / Sign up

Export Citation Format

Share Document